Evidence map›Paper›PMID 28611244›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2018

James C Davis, Najat C Daw, Fariba Navid, Catherine A Billups, Jianrong Wu, Armita Bahrami, Jesse J Jenkins, Scott E Snyder, Wilburn E Reddick, Victor M Santana and 3 more

Open access · bronzeAbstract readClinical Trial, Phase II
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. SUVmax onBioMed research international · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Metabolic response as assessed byCancer medicine · 2021
    Article
  15. Article
  16. [EJNMMI research · 2020
    Article
  17. Article
  18. Article
  19. Global disease score (GDS) is the name of the game!European journal of nuclear medicine and molecular imaging · 2019
    Article
  20. Can pretreatmentEuropean radiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

James C DavisDepartment of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
Najat C DawDepartment of Pediatrics, M.D. Anderson Cancer Center, Houston, Texas.
Fariba NavidDepartment of Pediatrics, Children's Hospital of Los Angeles, Los Angeles, California.
Catherine A BillupsDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
Jianrong WuDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
Armita BahramiDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee; and.
Jesse J JenkinsDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee; and.
Scott E SnyderDepartment of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
Wilburn E ReddickDepartment of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
Victor M SantanaDepartment of Pediatrics, Children's Hospital of Los Angeles, Los Angeles, California.
M Beth McCarvilleDepartment of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
Junyu GuoDepartment of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
Barry L ShulkinDepartment of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee Barry.shulkin@stjude.org.
St. Jude Children's Research Hospital · USChildren's Hospital of Los Angeles · USThe University of Texas MD Anderson Cancer Center · USUniversity of Southern California · USUniversity of Tennessee Health Science Center · US

Funding

PROFESSIONAL ONCOLOGY EDUCATION PROGRAMR25CA023944 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SUZANNE A. GRONEMEYER · 1986 to 2026
$8.3M
NCI NIH HHS R25 CA023944
6 · The paper itself

Abstract

The purpose of this study was to determine the relationship of

Indexed as

Chemotherapy, AdjuvantAdolescentAdultBiological TransportChildDisease-Free SurvivalFemaleFluorodeoxyglucose F18HumansMaleOsteosarcomaPositron Emission Tomography Computed TomographyTime FactorsFluorodeoxyglucose F1818F-FDGosteosarcomapediatricsPET/CT

Identifiers

PMID28611244
PMCPMC5750521
OpenAlexW2626130041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.